Currently, there are 11.98M common shares owned by the public and among those 10.20M shares have been available to trade.
Insiders at the company have transacted a total of 18 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 11 of these insider trades were purchases, accounting for 1,148,378 shares. Insider sales of the common stock occurred on 7 occasions, with total insider shares sold totaling 99,483 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of 59.82% and 12.90% over the past three months. YTEN shares are trading 46.26% year to date (YTD), with the 12-month market performance down to -91.09% lower. It has a 12-month low price of $0.18 and touched a high of $3.96 over the same period. YTEN has an average intraday trading volume of 416.82K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 57.66%, 53.25%, and -68.89% respectively.
Institutional ownership of Yield10 Bioscience Inc (NASDAQ: YTEN) shares accounts for 5.32% of the company’s 11.98M shares outstanding.
It has a market capitalization of $4.19M and a beta (3y monthly) value of 1.53. The earnings-per-share (ttm) stands at -$2.48. Price movements for the stock have been influenced by the stock’s volatility, which stands at 22.96% over the week and 12.01% over the month.
Analysts forecast that Yield10 Bioscience Inc (YTEN) will achieve an EPS of -$0.28 for the current quarter, -$0.31 for the next quarter and -$0.94 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.31 while analysts give the company a high EPS estimate of -$0.23. Comparatively, EPS for the current quarter was -$0.67 a year ago. Earnings per share for the fiscal year are expected to increase by 27.17%, and 54.06% over the next financial year. EPS should shrink at an annualized rate of 0.00% over the next five years, compared to 53.83% over the past 5-year period.
Looking at the support for the YTEN, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on September 10, 2020, with the firm’s price target at $25.
